TY - JOUR
T1 - Long-term Outcomes of Transoral Outlet Reduction (TORe) for Dumping Syndrome and Weight Regain After Roux-en-Y Gastric Bypass
AU - Pontecorvi, Valerio
AU - Matteo, Maria Valeria
AU - Bove, Vincenzo
AU - De Siena, Martina
AU - Giannetti, Giulia
AU - Carlino, Giorgio
AU - Polidori, Giulia
AU - Vinti, Laila
AU - Angelini, Giulia
AU - Iaconelli, Amerigo
AU - Familiari, Pietro
AU - Raffaelli, Marco
AU - Costamagna, Guido
AU - Boskoski, Ivo
PY - 2023
Y1 - 2023
N2 - Background Both weight regain and dumping syndrome (DS) after Roux-en-Y gastric bypass (RYGB) have been related to the dilation of gastro-jejunal anastomosis. The aim of this study is to assess the safety and long-term efficacy of endoscopic transoral outlet reduction (TORe) for DS and/or weight regain after RYBG.Materials and Methods A retrospective analysis was performed on a prospective database. Sigstad's score, early and late Arts Dumping Score (ADS) questionnaires, absolute weight loss (AWL), percentage of total body weight loss (%TBWL), and percentage of excess weight loss (%EWL) were assessed at baseline and at 6, 12, and 24 months after TORe.Results Eighty-seven patients (median age 46 years, 79% female) underwent TORe. The median baseline BMI was 36.2 kg/m(2). Out of 87 patients, 58 were classified as "dumpers " due to Sigstad's score & GE; 7. The resolution rate of DS (Sigstad's score < 7) was 68.9%, 66.7%, and 57.2% at 6, 12, and 24 months after TORe, respectively. A significant decrease in Sigstad's score as well as in early and late ADS questionnaires was observed (p < 0.001). The median Sigstad's score dropped from 15 (11-8.5) pre-operatively to 2 (0-12) at 24 months. The %TBWL was 10.5%, 9.9%, and 8.1% at 6, 12, and 24 months, respectively. Further, "dumpers " with resolution of DS showed better weight loss results compared with those with persistent DS (p < 0.001). The only adverse event observed was a perigastric fluid collection successfully managed conservatively.Conclusion TORe is a minimally invasive treatment for DS and/or weight regain after RYGB, with evidence of long-term efficacy.
AB - Background Both weight regain and dumping syndrome (DS) after Roux-en-Y gastric bypass (RYGB) have been related to the dilation of gastro-jejunal anastomosis. The aim of this study is to assess the safety and long-term efficacy of endoscopic transoral outlet reduction (TORe) for DS and/or weight regain after RYBG.Materials and Methods A retrospective analysis was performed on a prospective database. Sigstad's score, early and late Arts Dumping Score (ADS) questionnaires, absolute weight loss (AWL), percentage of total body weight loss (%TBWL), and percentage of excess weight loss (%EWL) were assessed at baseline and at 6, 12, and 24 months after TORe.Results Eighty-seven patients (median age 46 years, 79% female) underwent TORe. The median baseline BMI was 36.2 kg/m(2). Out of 87 patients, 58 were classified as "dumpers " due to Sigstad's score & GE; 7. The resolution rate of DS (Sigstad's score < 7) was 68.9%, 66.7%, and 57.2% at 6, 12, and 24 months after TORe, respectively. A significant decrease in Sigstad's score as well as in early and late ADS questionnaires was observed (p < 0.001). The median Sigstad's score dropped from 15 (11-8.5) pre-operatively to 2 (0-12) at 24 months. The %TBWL was 10.5%, 9.9%, and 8.1% at 6, 12, and 24 months, respectively. Further, "dumpers " with resolution of DS showed better weight loss results compared with those with persistent DS (p < 0.001). The only adverse event observed was a perigastric fluid collection successfully managed conservatively.Conclusion TORe is a minimally invasive treatment for DS and/or weight regain after RYGB, with evidence of long-term efficacy.
KW - Bariatric endoscopy
KW - Dumping syndrome
KW - Weight regain
KW - Obesity
KW - Transoral outlet reduction
KW - Gastric bypass
KW - Bariatric endoscopy
KW - Dumping syndrome
KW - Weight regain
KW - Obesity
KW - Transoral outlet reduction
KW - Gastric bypass
UR - http://hdl.handle.net/10807/231290
U2 - 10.1007/s11695-023-06466-w
DO - 10.1007/s11695-023-06466-w
M3 - Article
SN - 0960-8923
SP - N/A-N/A
JO - Obesity Surgery
JF - Obesity Surgery
ER -